Increased susceptibility of breast cancer cells to stress mediated inhibition of protein synthesis

Cancer Res. 2008 Jun 15;68(12):4862-74. doi: 10.1158/0008-5472.CAN-08-0074.

Abstract

Protein synthesis is a tightly controlled process, and its deregulation plays an important role in tumorigenesis. Protein synthesis remains poorly understood with very few well-identified validated targets for therapeutic purposes. In this study, we use nitric oxide (NO), which suppresses protein synthesis by inactivating eukaryotic initiation factor 2-alpha (eIF2-alpha), to examine the mechanism by which low and high oxidative stress inhibits protein synthesis. In breast cancer cells, low NO stress induced heme-regulated inhibitor (HRI) activation, which facilitated gradual decline in short half-life proteins. High NO stress induced HRI and protein kinase R (PKR) activation, leading to a sharp decline in protein synthesis as accessed by a decline in short and long half-life proteins and dramatic morphologic changes. In contrast, human mammary epithelial (HME) and Ras transfected untransformed HME (MCF-10A1 neo N) cells were less susceptible to NO-induced inhibition of protein synthesis and cytostasis. Our results suggest that NO-induced cytostasis in breast cancer cells was due to PKR activation and increased phosphorylation of eIF2-alpha, whereas the reduced susceptibility of normal mammary epithelial cells to NO could be due to the inaccessibility of PKR, which is bound to inhibitor p58.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis / drug effects
  • Blotting, Western
  • Breast / cytology
  • Breast / metabolism
  • Breast Neoplasms / genetics
  • Breast Neoplasms / metabolism*
  • Breast Neoplasms / pathology*
  • Cell Cycle / drug effects
  • Cell Transformation, Neoplastic
  • Cells, Cultured
  • Culture Media, Serum-Free / pharmacology
  • Cyclic GMP / metabolism
  • Enzyme Activation / drug effects
  • Eukaryotic Initiation Factor-2 / antagonists & inhibitors
  • Eukaryotic Initiation Factor-2 / genetics
  • Eukaryotic Initiation Factor-2 / metabolism*
  • Female
  • Free Radical Scavengers / pharmacology
  • Genes, ras / physiology
  • Heme / chemistry
  • Humans
  • Hydrogen Peroxide / pharmacology
  • Immunoprecipitation
  • Mitogen-Activated Protein Kinase 1 / metabolism
  • Mitogen-Activated Protein Kinase 3 / metabolism
  • Nitric Oxide / pharmacology*
  • Oxidants / pharmacology
  • Oxidative Stress*
  • Phosphorylation / drug effects
  • Protein Biosynthesis / physiology*
  • RNA, Small Interfering / pharmacology
  • eIF-2 Kinase / antagonists & inhibitors
  • eIF-2 Kinase / metabolism

Substances

  • Culture Media, Serum-Free
  • Eukaryotic Initiation Factor-2
  • Free Radical Scavengers
  • Oxidants
  • RNA, Small Interfering
  • Nitric Oxide
  • Heme
  • Hydrogen Peroxide
  • eIF-2 Kinase
  • Mitogen-Activated Protein Kinase 1
  • Mitogen-Activated Protein Kinase 3
  • Cyclic GMP